Our Editorial Board Members work closely with the in-house editors to ensure that all manuscripts are subject to the same editorial standards and journal policies. Editorial Board Members are active researchers recognized as experts in their field. Our Editorial Board Members handle manuscripts within their areas of expertise, overseeing all aspects of the peer review process from submission to acceptance. To learn more about our collaborative editorial model, read this editorial from 11 October 2019.
Interested in joining the editorial board?
We will be expanding our editorial board as the journal grows. If you are interested in becoming an Editorial Board Member for Communications Biology, please complete this Google form. If you are unable to use Google forms, you may contact us with your CV and/or link to your lab webpage, the subject areas you would like to cover for the journal, and a brief statement about why you are interested in an editorial board member position. Please note that your personal information, including name and email address, will be kept by the in-house editors for the sole purpose of identifying potential editorial board members. If you would like us to delete your information at any time, please contact us.
Please note that we are not able to respond to all applicants.
Editorial Board Members by subject area
Learn more about our Editorial Board Members below.
- César de la Fuente
- Robert DeLong
- Ngan Huang
- Periklis Pantazis
- Yuedong Yang
- Chao Zhou
- Zheng-Jiang Zhu
- Manidipa Banerjee
- Alexander Cartagena-Rivera
- Krishnananda Chattopadhyay
- Marco Fritzsche
- Noriko Hiroi
- Janesh Kumar
- Nicholas Kurniawan
- Tatiana Kutateladze
- Ingrid Span
- Georgios Giamas
- Toril Holien
- Marina Holz
- Ruby Huang
- Erik Knudsen
- Guideng Li
- Vivian Lui
- Ana-Teresa Maia
- Maralice Sorrell
- Margareta Wilhelm
- Tiago Dantas
- Natalie Elia
- Gregory Lavieu
- Yuting Ma
- Gracjan Michlewski
- Toshiro Moroishi
- Valeria Naim
- Elah Pick
- Liming Sun
- Katie Davis
- Nicolas Desneux
- Linn Hoffmann
- Zuzana Hofmanová
- Richard Holland
- Michelle Lawing
- Shouli Li
- Quan-Xing Liu
- Luciano Matzkin
- Nandini Rajamani
- Laura Rogers-Bennett
- Hannes Schuler
- Frank Avila
- Melanie Bahlo
- Simona Chera
- Hélène Choquet
- Pei Hao
- Kaoru Ito
- Chiea Chuen Khor
- Eirini Marouli
- Edwina McGlinn
- Patrick Murphy
- Néstor Oviedo
- Jun Wei Pek
- Mireya Plass Pórtulas
- Debarka Sengupta
- Eirini Trompouki
- Kaiwen Chen
- Deborah Fuller
- Joanna Hester
- Shitao Li
- Si Ming Man
- Sridhar Mani
- Lim Theam Soon
- Damon Tumes
- Anna Heintz-Buschart
- Nishith Gupta
- Calvin Henard
- Thulani Makhalanyane
- Meritxell Riquelme
- Sine Lo Svenningsen
- Kevin Theis
- Daniel Bendor
- Christian Beste
- Thiago Cunha
- Jacqueline Gottlieb
- Ivo Lieberam
- Jeanette Mumford
- Alex Nord
- Stefano Palminteri
- Eliana Scemes
- Enzo Tagliazucchi
- Michel Thiebaut de Schotten
- Christian Wozny
- Juan (Helen) Zhou
- Jesmond Dalli
- Christopher Hine
- Kyle Hoehn
- Tami Martino
- Loredana Quadro
- Martina Rauner
- Gabriela da Silva Xavier
Research areas: G protein-coupled receptors, peptides, cell signaling, drug development
Professor Ross Bathgate is the co-leader of the Discovery Science Theme at the Florey Institute of Neuroscience and Mental Health and is an Honorary Professorial Fellow in the Department of Biochemistry and Molecular Biology at the University of Melbourne, Australia. He is a molecular pharmacologist with broad expertise in bioactive peptides and their G protein-coupled receptors (GPCRs). A major focus of his lab is understanding the interactions of peptide ligands with their GPCR targets for the development of peptide-based drugs and utilizing structure-based drug design to develop novel therapeutics. His GPCR-targeted drug development research involves many potential therapeutic areas including cardiovascular disease, fibrosis and neurological disorders. Additionally, his lab develops recombinant viral systems involving approaches to target neuropeptide GPCRs and novel modified chemogenetic and optogenetic constructs for dissecting neural circuits.
Research areas: Protein biochemistry, proteomics, membrane protein biology, mass spectrometry, post-translational modifications, neuroproteomics
Dr. Mark Collins is a Senior Lecturer in the Department of Biomedical Science and Deputy Director of the Faculty of Science Mass Spectrometry Centre at the University of Sheffield. He undertook his B.Sc. in Biochemistry and Molecular Genetics at University College Dublin and his Ph.D. in Molecular Neuroscience at the University of Edinburgh where he developed and applied biochemical approaches to characterise synaptic proteomes. He spent 8 years working as a staff/senior staff scientist in the area of mass spectrometry-based proteomics at the Wellcome Sanger Institute before setting up his own research group at the University of Sheffield. His group is interested in the trafficking and interaction of membrane proteins and how their function is regulated by post-translational modifications.
Research areas: Protein biochemistry, protein engineering, ubiquitination, organelle biology
Dr. Min Zhuang is an Assistant Professor in the School of Life Science and Technology at ShanghaiTech University in Shanghai, China. She obtained the Ph.D. in Structural Biology in a joint program from the University of Tennessee Health Science Center and St. Jude Children’s Research Hospital. Prior to joining the faculty at ShanghaiTech, she completed postdoctoral training in the Department of Pharmaceutical Chemistry at University of California San Francisco. Dr. Zhuang has broad expertise in structural biology, protein biochemistry and ubiquitination. Currently, her lab is developing new protein proximity labeling tools to facilitate the identification of weak protein-protein interactions. She is also interested in understanding the role of ubiquitination in organelle quality control.
Research areas: RNA biochemistry, RNA-protein interactions, RNA modifications, RNAi, CRISPR biology and technology, structural biology, biochemistry
Dr. Audrone Lapinaite is an assistant professor at the School of Molecular Sciences and the Biodesign Institute's Neurodegenerative Disease Research Center at ASU. She received her PhD from the European Molecular Biology Laboratory (EMBL), Heidelberg, where she was working on understanding the molecular basis of multicomponent ribosomal RNA methyltransferase using a combination of high-resolution (solution state NMR) and low-resolution (small angle neutron/X-ray scattering) techniques. She carried out her postdoctoral research at UC Berkeley mentored by Dr. Jennifer A. Doudna and Dr. Jamie H. D. Cate. She investigated the molecular mechanism of programmable DNA base editors (a fusion of CRISPR-Cas9 and either adenine or cytosine deaminases) and characterized a CRISPR-locus associated programmable RNA and DNA binding Argonaute. Audrone Lapinaite is the recipient of a prestigious Human Frontier Science Program (HFSP) postdoctoral fellowship. Now at ASU her group focuses on elucidating the molecular mechanisms underlying the functional role of RNA modifications in neurons in normal and pathological states using state-of-art structural and molecular biology approaches, including CRISPR-Cas mediated DNA and RNA targeting technologies. Her lab is also interested in characterizing and harnessing bacterial defense systems (e.g. CRISPR, restriction-modification etc.) for biotechnological and therapeutic applications.
Research areas: DNA repair, nucleoid organisation, anticancer drug resistance, radiation resistance
Dr. Joanna Timmins obtained her B.A. in Natural Sciences from Cambridge University, UK, before moving to the EMBL Grenoble outstation, where she performed her Ph.D. She then conducted her post-doctoral training followed by a 5-year scientist position at the European Synchrotron Radiation Facility (ESRF), where she became interested in the DNA repair machinery of the radiation-resistant bacterium, Deinococcus radiodurans. Since 2011, Dr. Timmins is Head of the ‘DNA Damage and Repair’ team at the Structural Biology Institute (IBS) in Grenoble, France. Her team is particularly interested in the molecular mechanisms underlying the recognition of DNA lesions amidst a vast excess of undamaged DNA, which constitutes the initial step of all DNA repair pathways. Her research focuses on DNA repair in D. radiodurans, but also in humans in the context of anticancer drug resistance. More recently, she has also become interested in chromatin organization and dynamics in bacteria, and how they affect processes such as DNA repair. Her team uses a combination of biochemical, biophysical, structural biology and cell imaging approaches to tackle these challenging projects.
Bioengineering & Biotechnology
César de la Fuente
Research areas: Synthetic biology, microbiology, computational biology
César de la Fuente, Ph.D. is a Presidential Assistant Professor at the University of Pennsylvania, where he is leading the Machine Biology Group to integrate synthetic biology, microbiology, and AI. Prof. de la Fuente seeks to expand nature’s repertoire to build novel synthetic molecular tools and devise therapies that nature has not previously discovered. The Machine Biology Group aims to develop computer-made tools and medicines that will replenish our current antibiotic arsenal and engineer the microbiome. Prof. de la Fuente was recognized by MIT Technology Review in 2019 as one of the world’s top innovators for “digitizing evolution to make better antibiotics”. He was selected as the inaugural recipient of the Langer Prize (2019), an ACS 2020 Kavli Emerging Leader in Chemistry (2020), AIChE’s 35 Under 35 Award (2020), and received the ACS Infectious Diseases Young Investigator Award (2020). In addition, he was named a Boston Latino 30 Under 30, a 2018 Wunderkind by STAT News, a Top 10 Under 40 of 2019 by GEN, a Top 10 MIT Technology Review Innovator Under 35 (Spain), 30 Rising Leaders in the Life Sciences by In Vivo magazine, and he received the 2019 Society of Hispanic Professional Engineers Young Investigator Award. His scientific discoveries have yielded over 75 peer-reviewed publications and multiple patents.
Research areas: Nanobiochemistry, nanobiotechnology, nanomedicine, cancer nanotechnology
Dr. Rob DeLong is an Associate Professor and founding core faculty member in the nanotechnology innovation center in the Department of Anatomy and Physiology at Kansas State University. He holds masters and PhD degrees in chemistry, biophysics and biochemistry from the University of Rochester and the Johns Hopkins University and led research groups in biopharma prior to returning to academia and starting his own lab between 2007 to 2009. His group studies the impact nano materials have on the structure, function, activity and delivery of RNA and proteins. The group is particularly interested in physiological metal, metal oxide, sulfide or selenide materials and their composites (physiometacomposites) and interfaces with proteins and nucleic acids, their fluoro-luminescent characteristics and anticancer activity.
Research areas: Biomedical engineering, cardiovascular & musculoskeletal diseases, stem cells
Dr. Ngan F. Huang is an Assistant Professor in the Department of Cardiothoracic Surgery at Stanford University and Principal Investigator at the Veterans Affairs Palo Alto Health Care System. Dr. Huang completed her BS in Chemical Engineering from the Massachusetts Institute of Technology, followed by a PhD in bioengineering from the University of California Berkeley & University of California San Francisco Joint Program in Bioengineering. Prior to joining the faculty, she was a postdoctoral scholar in the Division of Cardiovascular Medicine at Stanford University. Her laboratory investigates the interactions between stem cells and extracellular matrix microenvironment for engineering cardiovascular tissues to treat cardiovascular and musculoskeletal diseases. Dr. Huang has authored over 60 publications and patents, including reports in Nature Medicine, PNAS, and Nano Letters. She has received numerous honors, including a NIH K99/R00 Career Development Award, Fellow of the American Heart Association, a Young Investigator award from the Society for Vascular Medicine, a Young Investigator Award from the Tissue Engineering and Regenerative Medicine International Society-Americas, and a Rising Star award at the Cell & Molecular Bioengineering conference. Her research is funded by the NIH, Department of Defense, California Institute of Regenerative Medicine, and Department of Veteran Affairs.
Research areas: Photoconvertible fluorescent proteins, nanoprobes, sensors and live optical precision imaging
Periklis Pantazis is a Reader in Advanced Optical Precision Imaging (equiv. Associate Professor) at the Department of Bioengineering at Imperial College London. He studied Biochemistry at the Leibniz University of Hannover, Hannover, Germany followed by a PhD in Biology and Bioengineering at the Max Planck Institute of Molecular Cell Biology and Genetics in Dresden, Germany. He pursued then postdoctoral studies at the California Institute of Technology in Pasadena, CA, USA before joining as an Assistant Professor the ETH Zurich Department of Biosystems Science and Engineering in Basel, Switzerland. In 2018/2019, he established his Laboratory of Advanced Optical Precision Imaging at Imperial College London that conceives and applies cutting-edge imaging technologies, assays and reagents for the mechanistic dissecting of development, disease progression and tissue regeneration.
Research areas: Protein structure prediction, drug design, multi-omics data analysis
Dr Yuedong Yang is Professor in the School of Computer Science and Engineering and National Super Computer Center at Guangzhou, Sun yet-sen University, China. He obtained his PhD degree from the University of Science and Technology of China. Afterward he continued his research in Indiana University, USA and later moved to Griffith University, Australia. Dr Yang has developed >20 bioinformatics tools that are widely used in the world, and published >100 articles in the fields of protein structure and function prediction, drug design, and genomic data analysis, etc. Currently his research group emphasizes on developing HPC and AI algorithms for cross-scale integration of multi-omics data and intelligent drug design. He is also responsible for constructing the HPC platform for biomedical applications based on the Tianhe-2 supercomputer.
Research areas: Optical microscopy, label-free imaging, optogenetic pacing, developmental biology, cancer, clinical translation
Dr. Chao Zhou is an associate professor in the Biomedical Engineering Department at the McKelvey School of Engineering at Washington University in St. Louis. He obtained his Bachelor’s degree from Peking University, a Ph.D. degree from the University of Pennsylvania, and received post-doctoral training from Massachusetts Institute of Technology. Before joining Washington University in 2019, he was an associate professor in the Department of Electrical and Computer Engineering and a founding member of the Department of Bioengineering at Lehigh University. He has extensive experience in biophotonics and has contributed to the development and validation of novel optical imaging and stimulation modalities for various biomedical applications ranging from basic research to clinical translation. His lab develops tools for label-free 3D imaging and characterization of biological samples in vitro (such as, tumor spheroids, tissue organoids) and in vivo ( eyes, skins, brains for instance), as well as optogenetic pacing technologies in model organisms, such as Drosophila melanogaster.
Research areas: Metabolomics, lipidomcis, mass spectrometry, bioinformatics, clinical and biological applications of metabolomics
Dr. Zheng-Jiang Zhu is a Professor in Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences (CAS) in Shanghai, China. He obtained his Ph.D. degree from University of Massachusetts at Amherst, United States. Then, he moved to The Scripps Research Institute (TSRI) as a Postdoctoral Research Associate with Prof. Gary Siuzdak, and worked on metabolomics and bioinformatics. Since 2013, Dr. Zhu joined CAS as an independent Principal Investigator. He has a very broad expertise in mass spectrometry, metabolomics, lipidomics, bioinformatics, clinical and biological applications of metabolomics/lipidomics. Currently, the research in Dr. Zhu lab focuses on the development of mass spectrometry-based metabolomics and lipidomics technologies, and related applications in studying aging metabolism, brain metabolism and neurodegenerative diseases.
Biophysics & Structural Biology
Research areas: Virus disassembly, role of viroporins in viral entry and egress, antiviral development, virus-based nanoparticles
Dr. Manidipa Banerjee is currently an Associate Professor at the Kusuma School of Biological Sciences, Indian Institute of Technology Delhi. Dr. Banerjee received her PhD from the University of California, San Diego, and carried out postdoctoral research at the Scripps Research Institute, California. The research interests of her laboratory are in the molecular mechanism of virus-host interaction, and in developing antiviral therapeutics and virus-based nanoparticles for biomedical applications. Her laboratory uses Flock House Virus (FHV) as a model system for structural analysis of non-enveloped icosahedral virus disassembly. The role of viral membrane proteins in entry and egress of viruses from host cells is being studied in context of Hepatitis A Virus and Chikungunya Virus (CHIKV). Dr. Banerjee’s laboratory utilizes a combination of techniques including molecular virology, cryoelectron microscopy and computational biology to address research questions.
Research areas: Mechanobiology, biophysics, atomic force microscopy, cellular mechanics, tissue mechanics
Dr. Alexander Cartagena-Rivera received his Ph.D. in Mechanical Engineering from Purdue University. He completed a Post-Doctoral IRTA Fellowship in the National Institute on Deafness and Other Communication Disorders at the National Institutes of Health (NIH). He is now an Earl Stadtman (Tenure-Track) Investigator and chief of the Section on Mechanobiology at the National Institute of Biomedical Imaging and Bioengineering at the NIH, where his laboratory research focuses on understanding the cellular and tissue molecular-mechanical regulation and development of advanced Atomic Force Microscopy tools for cancer biology and hearing research. In 2019 he received the prestigious NIH Distinguished Scholars Program award. His research interests lie in diverse and multidisciplinary fields including mechanobiology, biophysics, fluid mechanics, soft matter, micro/nanomechanics, hearing mechanics, tissue mechanics, cellular biology, and living cells and viruses mechanics determined using the atomic force microscope in physiologically relevant conditions.
Research areas: Biophysics, structural biology, fluorescence spectroscopy
Dr. Krishnananda Chattopadhyay is the Head of the Structural Biology and Bioinformatics Division at the CSIR-Indian Institute of Chemical Biology (IICB), Kolkata, India. He is also a Professor of the Academy of Scientific and Innovative Research. His group works on protein folding and aggregation and their implications in neurodegenerative diseases, using a variety of computational, biochemical, biophysical and analytical techniques. He is particularly interested in developing applications of single molecule fluorescence spectroscopy to monitor the early and unexplored events of protein aggregation. Krish obtained his PhD from Tata Institute of Fundamental Research, Mumbai. During his post-doctoral studies with Professor Carl Frieden and in close collaboration with Professor Elliot Elson at the Washington University School of Medicine, he studied the conformational dynamics of the unfolded states of a protein under single molecule resolution using fluorescence correlation spectroscopy (FCS). Before joining IICB, he worked as a Senior Scientist in the Product Development group at Pfizer Global Biologics, Saint Louis. He is the recipient of Royal Society of Chemistry and IUSTF fellowship awards.
Research areas: Immunology, mechanobiology, biophysics, microscopy
Assoc Professor Marco Fritzsche leads the Biophysical Immunology Laboratory (www.bpi-oxford.com) between the Rosalind Franklin Institute and the Kennedy Institute for Rheumatology at the University of Oxford, UK. The BPI Laboratory aims to unravel the impact of biophysics and mechanobiology on the human immune response in health and disease. For this mission, the BPI lab develop custom-built microscopy technology at the interface of biophysics and immunology. Dr. Fritzsche holds a MSc in theoretical physics and conducted his PhD in experimental biophysics and cell-biology at the London Centre for Nanotechnology at the University College London, UK. He performed his Postdoctoral work at the University of Oxford in close collaboration with the Howard Hughes Medical Institute Janelia Farm, USA.
Research areas: Quantitative biology, systems biology, biophysics, biothermology, microfluidics
Prof. Noriko F. Hiroi received her Ph.D. from the University of Tokyo, Graduate School of Medicine. After graduated the Ph.D. course, she has established whole of her career with interdisciplinary researches. She began her first postdoc at ERATO Kitano Symbiotic Systems Project, and joined EMBL-EBI Interdisciplinary Postdoc project in Cambridge UK. During the term, she started to contribute to Quantitative Biology cooperating with world-wide researchers in the area. After she moved back to Japan, Keio University, she has more concentrated on Biophysical approaches, including to develop experimental tools by applying optics, quantum processes and microfluidics. Now she launched her independent laboratory as the Laboratory of Physical Chemistry for Life Science from 2018, April. She received the Konica Minolta Imaging Science Award in 2014. She is a member of the Royal Society of Chemistry, and Cambridge Biological Society, Japanese Society for Quantitative biology, Quantum Life Science Society, Japan Society of Applied Physics, The Pharmaceutical Society of Japan.
Research areas: Membrane proteins, glutamate receptor ion channels, cryo-electron microscopy, x-ray crystallography, structural biology
Dr. Janesh Kumar is a Senior Scientist at the National Centre for Cell Science (NCCS), Pune. Dr. Kumar’s team focuses on the structure, function and regulation of glutamate receptor ion channels that play key roles in synaptic neurotransmission and plasticity. Dr. Kumar received his PhD degree from All India Institute of Medical Sciences, New Delhi in 2007 working on the structural biology of secretory glycoproteins under the supervision of Prof. Tej P. Singh. Following this, he carried out postdoctoral research at NICHD, NIH, Bethesda mentored by Dr. Mark L. Mayer. During the six years at NIH, he investigated the mechanisms of ionotropic glutamate receptor assembly, activation and desensitization. Dr. Kumar won the Fellows Award in Research Excellence (FARE) at NIH twice in 2011 and 2012 respectively. He was awarded the Wellcome Trust/DBT India Alliance Intermediate Fellowship and Ramanujan Fellowship in 2013.
Research areas: Cell biophysics, cell-materials interactions, mechanobiology, tissue regeneration
Dr. Nicholas Kurniawan is an Assistant Professor at the Department of Biomedical Engineering in Eindhoven University of Technology, the Netherlands. He obtained his PhD from the National University of Singapore, after which he performed a postdoctoral research in AMOLF, the Netherlands. His current research focuses on understanding how the physical and mechanical interactions between cells and cellular environments shape physiological tissue function and drive pathologies. His interdisciplinary team combines approaches from biophysics, mechanobiology, microfabrication, and cell biology with an outlook of exploiting cell–materials interactions for regenerative medicine applications. He was the recipient of several prestigious research awards, including Marie Curie Postdoctoral Fellowship and the European Research Council (ERC) Starting Grant.
Research areas: Chromatin biology, epigenetics, structural biology
Tatiana Kutateladze is a Professor in the Department of Pharmacology at the University of Colorado School of Medicine. Her research interests include studying epigenetic and chromatin remodeling signaling, posttranslational histone modifications and the role of epigenetic misregulations in human diseases. Tatiana’s laboratory applies high field NMR spectroscopy and X-ray crystallography to obtain atomic-resolution structures of chromatin-binding proteins involved in transcriptional regulation and DNA damage repair. Among their major achievements, the Kutateladze’s lab is credited with determining molecular bases underlying methyllysine and acyllysine recognition by a large number of epigenetic readers.
Research areas: Structural biology, metalloenzymes
Dr. Ingrid Span received her PhD from Technical University Munich, where she received the Emil Erlenmeyer Medal for outstanding achievements, and carried out her postdoctoral work at Northwestern University in the US. Dr. Span is a recipient of the Liebig fellowship of the Foundation of Chemical Industry and has received research fellowship and return grants from the German Research Foundation (DFG). She has been an independent researcher at Heinrich Heine University in Düsseldorf since 2014 and currently holds the title of Junior Professor. Dr. Span’s group investigates the structure and function of metalloproteases and the synthesis and characterization of artificial metalloenzymes.
Research areas: Cancer, cell signaling, proteomics
Professor Georgios Giamas obtained his Biology degree (BSc) at the National and Kapodistrian University of Athens in Greece. He then undertook his Doctoral degree (PhD - Magna Cum Laude) at the University of Ulm (Germany). Following postdoctoral work at the University of Ulm, he moved to Imperial College London at 2007, working as a Research Associate in the Division of Surgery and Cancer. In 2011 he was awarded Imperial College's prestigious Junior Research Fellowship. In 2012 he was awarded a NIHR Senior Research Fellowship and was appointed as a Research Team Leader. In July 2015, he became an Associate Professor (Reader) in Cell Signalling at University of Sussex while holding an honorary contract (Visiting Reader) with Imperial College. Since May 2018, he is a Professor at the department of Biochemistry and Biomedicine at University of Sussex.
Research areas: Signal transduction, apoptosis, cancer, hematology, oncogenes, drug development
Dr. Toril Holien is a researcher and group leader with a PhD in Molecular Medicine from the Norwegian University of Science and Technology (NTNU) in Trondheim, Norway. She has a bacground as a Biomedical Laboratory Scientist and worked in clinical diagnostic labs as well as research labs before she did her PhD. Holien’s group at the Department of Clinical and Molecular Medicine, NTNU, is part of a larger translational research environment focusing on multiple myeloma and their lab is located in St. Olavs’s University Hospital. Her main research interest is how cell signaling pathways affect cell growth and survival, and how this can be targeted clinically for the benefit of patients. The group led by Holien studies TGF-β/BMP-signaling, or more specifically, mechanisms for ligand-receptor interactions and how these regulate downstream signaling.
Research areas: Cancer, rare diseases, signal transduction
Marina K. Holz, Ph.D., dean of the Graduate School of Basic Medical Sciences (GSBMS) and professor of Cell Biology and Anatomy at New York Medical College. Dr. Holz received her B.Sc. in Microbiology and Immunology with Great Distinction from McGill University and completed her Ph.D. in Cell and Developmental Biology at Harvard Medical School in the lab of Dr. John Blenis. At NYMC, Dr. Holz leads an NIH-funded laboratory studying the mechanisms of signaling by hormones and growth factors in breast cancer and lymphangioleiomyomatosis (LAM) — a rare lung disease. Her work spans basic science and clinical applications, and has been published in leading journals. The Holz lab has been previously funded by grants from the American Cancer Society (ACS), LAM Foundation, Wendy Will Case Cancer Fund, American Association for Cancer Research (AACR), Mindlin Foundation, National Cancer Center, and Atol Foundation. Dr. Holz is the Community Ambassador for the American Cancer Society, and serves as a mentor and coach in several diversity initiatives organized by the National Research Mentoring Network, the American Society for Biochemistry and Molecular Biology, the American Society for Cell Biology, and others.
Research areas: Cancer, epithelial-mesenthymal transition (EMT), metastasis
Professor Ruby Yun-Ju Huang is a clinician scientist in the international ovarian cancer and EMT research field. She is best known to define the early events of EMT and to propose the paradigm shift of the EMT concept from binary to a continuous spectrum. She also dedicates in the understanding of the underlying biology of the gene expression molecular subtypes in ovarian cancer. She obtained MD and PhD degree from National Taiwan University (NTU) and completed the residency training of Obstetrics & Gynecology and subspecialty fellowship training of gynecologic/surgical oncology in National Taiwan University Hospital (NTUH). Following her postdoctoral studies with Prof. Jean Paul Thiery at Institute of Molecular and Cell Biology (IMCB) in Singapore, she joined the Department of Obstetrics & Gynaecology at the National University Hospital (NUH) of Singapore and the Cancer Science Institute (CSI) of Singapore in National University of Singapore (NUS) to lead the ovarian cancer research program. Under the Yushan Scholar Program awarded by Ministry of Education in Taiwan, she subsequently returned to NTU School of Medicine as a Professor in 2019. Her group, EMPreSS (Epithelial Mesenchymal Precision Spectrum Scoring), focuses on the understandings of gatekeeping of the epithelial state, the approximation of the mesenchymality, and the fluidity/plasticity of the interchange among different states by using ovarian cancer as the disease model.
Research areas: Cell biology, epigenetics, cancer biology, cell cycle regulation
Dr. Knudsen received his undergraduate degree in Chemistry and Biochemistry from University of Washington. He performed his graduate and post-doctoral training in cancer cell biology at the University of California San Diego. Dr. Knudsen has held academic appointments at the University of Cincinnati, Thomas, Jefferson University, UT Southwestern, and Roswell Park Cancer Center. His research group has evaluated multiple biologically relevant features of biology including: cell cycle regulatory mechanisms, epigenetic pathways, signal transduction machinery, and developmental therapeutics. Dr. Knudsen’s current work spans the elucidation of fundamental mechanisms of cancer biology through development of clinical trials. He serves as the Chair of Molecular and Cellular Biology at Roswell Park Cancer Center.
Research areas: Tumor microenvironment, T-cell antigen discovery, cancer immunology
Dr. Guideng Li is a Principal Investigator in Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences. He received his Ph.D. in immunology from University of California, Irvine (UCI), and pursued his postdoctoral research in California Institute of Technology (Caltech) with Dr. Nobel Laureate David Baltimore. Current research in the laboratory focuses on understanding the molecular mechanisms responsible for productive anti-tumor immune responses and developing new technologies and effective therapeutic strategies with potential clinical applications.
Research areas: Precision medicine, exceptional responder genomics and drug responses, immunogenomics, integrative multi-omics and bioinformatics
Dr. Vivian Lui is an Associate Professor in the School of Biomedical Sciences at the Chinese University of Hong Kong (CUHK). She obtained her B.Sc. (First Class Hons.) in Biochemistry at the same university, and her Ph.D. (Hons) in Molecular Pharmacology at the University of Pittsburgh School of Medicine, USA. After her post-doctoral training at Duke University and the University of Pittsburgh, she became an independent investigator specializing in translational cancer research, in particular in the areas of Precision Medicine development, exceptional responder genomics, immunogenomics, integrative head and neck cancer multi-omics and bioinformatics. She was awarded the Head and Neck SPORE (Special Program of Research Excellence Grant) Developmental Research Award by the National Cancer Institute (USA), a Visiting Professorship at Stanford University (by the SH Visiting Professorship Stanford-CUHK exchange program), and a prestigious Research Impact Fund on precision medicine development harnessing Exceptional Responder genomics in pan-cancer. In additional to her translational cancer research, Dr. Lui also serves in the National Society of Genetic Counselors (NSGC, USA) Pharmacogenomics working group to help promoting Pharmacogenomics for patient care.
Research areas: Cancer genomics, functional genomics, cis-regulatory variation, genetic risk, tumour evolution
Dr Ana-Teresa Maia is an Assistant Professor at the University of Algarve, Portugal, and Integrated Researcher at RISE, a national network of universities and research centres aiming at improving translational and clinical research in Portugal. She obtained her PhD at the Institute of Cancer Research, in London, United Kingdom. She then did post-doctoral training at the University of Cambridge, focusing on the identification and characterisation of cis-regulatory variation underlying breast cancer risk. Currently, she leads a group of geneticists and computational biologists using the allelic expression imbalance generated by these variants to develop new methods to study predisposition to breast cancer and to understand tumour evolution and treatment response.
Maralice Conacci Sorrell
Research areas: Cancer metabolism, cell growth, oncogenes and tumor suppressor, pathways regulated by Myc in normal and cancer cell biology, nucleolus
Maralice Sorrell is an Assistant Professor in Cell Biology and a member of the Harold C. Simmons Comprehensive Cancer Center and of the Hamon Center for Regenerative Science and Medicine at UT Southwestern Medical Center in Dallas. She completed her undergraduate education in Biology at University of Sao Paulo, her PhD in Molecular Cell Biology at the Weizmann Institute, and her postdoctoral training at the Fred Hutchinson Cancer Research Center. Dr Sorrell studies how oncogenes, particularly from the MYC family, alter cellular metabolism to promote nutrient uptake and biomass production leading to rapid proliferation. Her goal is to identify unique vulnerabilities of cancer cells that can be specifically manipulated by dietary or pharmacologic interventions to treat solid tumors.
Research areas: Cancer, tumor microenvironment, cell biology, disease modelling
Dr. Margareta Wilhelm is an Associate Professor of Tumor Biology at Karolinska Institutet in Stockholm, Sweden. She received her PhD in Experimental Oncology at Karolinska Institutet, and post-doctoral training at the Campbell Family Cancer Research Institute, in Toronto, Canada. Dr. Wilhelm was awarded an Assistant Professor position from the Swedish Research Council and a Young Investigator Award from the Swedish Cancer Society. Her research focus on understanding mechanisms regulating tumor initiation and progression with a specific interest in the tumor microenvironment and infiltrating immune cells. Her lab is using transgenic models, cellular reprogramming, stem cells, and organoids to model tumor development.
Cell & Molecular Biology
Research areas: Neurobiology, microtubule cytoskeleton-associated processes, ciliogenesis
Dr. Tiago Dantas is an Assistant Investigator at the Institute for Research and Innovation in Health (i3S), in Porto, Portugal. Dr. Dantas's team focuses on the poorly characterized form of cytoplasmic Dynein, known as Dynein-2, which is a molecular motor essential for retrograde intraflagellar transport inside cilia and is involved in many cell signaling pathways. He is also interested in understanding the ciliary-dependent signaling mechanisms that regulate cell cycle progression and proliferation of neural stem cells during brain development. Dr. Dantas received his PhD in Cell Biology and Biochemistry from the National University of Ireland Galway where he studied centrosome duplication and ciliogenesis under the supervision of Prof. Ciaran Morrison. During his 5 year postdoctoral training at Columbia University in New York, mentored by Prof. Richard Vallee, he investigated the importance of cytoplasmic Dyneins in brain development and how mutations in their subunits can contribute to diverse types of human disorders.
Research areas: Cell biology, ESCRT pathway, microscopy techniques
Dr. Natalie Elia is a Principal Investigator in the Department of Life Sciences and the National Institute for Biotechnology in the Negev (NIBN) at Ben Gurion University in Beer Sheva, Israel. She received her PhD in biochemistry at the Hebrew University in Jerusalem and, after becoming interested in live cell imaging, conducted her post-doctoral training in cell biology and super-resolution microscopy at the National Institutes of Health in the United States. Dr. Elia established her lab at Ben Gurion University in 2012 with a focus on understanding the cellular functions and mechanisms of ESCRTs in a physiological context. As part of this research, the Elia team uses unique light microscopy systems to achieve the high spatial and temporal resolution needed for observing protein dynamics and macromolecular architecture in living cells. Dr. Elia was awarded the Krill Prize for excellence in scientific research in 2015 and a Horizon 2020 European Research Council Starting Grant in 2014.
Research areas: Cell biology, membrane trafficking, extracellular vesicles, autophagy
Gregory Lavieu is a Cell Biologist/Biochemist expert in membrane trafficking. He is a permanent Investigator at INSERM (French National Institute of Health and Medical Research), and “Chaire d’Excellence” at Université de Paris, France. Lavieu’s most valuable scientific accomplishment is the discovery and the characterization of the Rim Progression, a mode of transport within the cell that is dedicated to large cargoes that cannot fit into classical transport vesicles. Gregory Lavieu is now focusing on the delivery of Extracellular Vesicles at the cellular and molecular levels.
Research areas: Cancer immunology, stress response, tumor microenvironment, Immunotherapy
Yuting MA received her PhD degree in Immunology from Université Paris sud 11, followed by post-doc trainings in INSERM, Institut Gustave Roussy, and Cordelier Research Center in Paris. To extend the pursuit of research in tumor immunology, she has established a laboratory in Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences since 2015. With the approaches of systems medicine, she aims to explore how various forms of stress responses and cell death modalities, including autophagy, apoptosis, necroptosis, ER stress, pyroptosis and ferroptosis, modulate the immunogenicity of cancer cells and the tumor immune microenvironment. In addition, her group aims to dissect the complex circuitries that link psychosocial distress to deleterious perturbations in the cancer-immune dialogue. Her continuous endeavors on these aspects led to over 50 highly-cited publications in prestigious scientific journals (including Nat Med, Nat Rev Immunol, Science, Immunity, etc) and book chapters. Yuting took the roles of Immunology Platform Director and Dean Assistant overseeing external communications and collaborations. She received Chinese Young Women Scientist Awards (2019) and Chinese Young Scientist Award for Cancer Research (2020).
Research areas: RNA biology, RNA processing, microRNAs, novel RNA-binding proteins, neurodegeneration, innate immunity
Professor Gracjan Michlewski is a Head of Dioscuri Centre for RNA-Protein Interactions in Human Health and Disease at the International Institute of Molecular and Cell Biology (IIMCB) in Warsaw, Poland. He is also an Honorary Lecturer at the University of Edinburgh, UK. He obtained PhD in Biochemistry with at Polish Academy of Sciences, Institute of Bioorganic Chemistry, Poznan, Poland where he solved RNA structures of toxic trinucleotide repeats that cause heritable neurodegenerative disorders. Prof. Michlewski has been a post-doctoral researcher mentored by Prof. Javier F. Cáceres at the Medical Research Council, Human Genetics Unit, Edinburgh, UK. He discovered regulatory pathways that control production of microRNAs. In 2011 he established his independent laboratory at the University of Edinburgh with a Medial Research Council Career Development Award. Before opening his Laboratory of RNA-Protein Interactions at the IIMCB in Warsaw in 2021, he was a Reader at the University of Edinburgh and Associate Professor at the Zhejiang University-University of Edinburgh Institute in Haining, China. His main research interests are associated with regulation of gene expression by non-coding RNAs, novel RNA-binding proteins, regulation of RNA processing in neurodegenerative disorders and innate immune response to RNA viruses.
Research areas: Cell biology, cell signaling, metabolism, immunology, cancer
Dr. Moroishi is a Professor of the Faculty of Life Sciences at Kumamoto University, Japan. He received his M.D. and Ph.D. in medical sciences from Kyushu University, Japan, and pursued his postdoctoral research at the University of California, San Diego, USA. Since 2017, Dr. Moroishi has been leading a research team studying cell signaling and cellular metabolism. His long-term research interests involve physiological mechanisms regulating tissue homeostasis and integrity in multicellular organisms, with a special focus on the interplay between metabolic and signal transduction pathways. His work spans from basic science to drug discovery, aiming to provide scientific basis for future clinical applications.
Research areas: DNA replication, recombination, repair; chromosome fragile sites; mitosis; chromosome instability syndromes; cancer
Dr. Valeria Naim is a Principal Investigator at Gustave Roussy European Cancer Centre. Since the beginning of her career, Dr. Naim has been interested in the mechanisms of maintenance of genome stability. She did her PhD in Genetics and Molecular Biology at the Sapienza University of Rome, in the laboratory of Prof. Maurizio Gatti. She characterized the function of genes that control mitotic cell division in Drosophila melanogaster. In 2007, she moved to France and joined the laboratory of Dr. Filippo Rosselli at Gustave Roussy as a Post-doctoral fellow. She found a role for proteins in the Fanconi anemia pathway during mitosis to prevent chromosomal instability in response to DNA replication stress. She was recruited by the INSERM (French Institute for Health and Medical Research) in 2010, and in 2015 she set up her group thanks to an ERC Starting Grant. The research interest of the lab is to understand the mechanisms that rescue cells from replication stress during mitosis and the role of chromosomal instability in cancer initiation and progression. Recently, the work of the team has focused on the crosstalk between mitochondrial function and nuclear dynamics in modulating transcription-replication conflicts and genome stability.
Research areas: Cell biology, protein biochemistry, proteolysis, membrane traffic, post-translational modification, S. cerevisiae
Dr. Elah Pick performed her graduate and postdoctoral training in cell Biochemistry, membrane traffic and proteolysis at the Technion – Israel Institute of Technology. She performed a second postdoctoral training at Yale university on a family of genes that regulate the molecular and biochemical mechanism responsible for light control of Arabidopsis development and show a high conservation across phyla, including in human. This group of gene products regulate cellular responses to external stimuli and stresses. To integrate the know-how, Elah Pick returned back to Israel and established her own lab at the department for Biology and Environment of the University of Haifa, located at Oranim, aiming to study evolutionary and environmental aspects of ubiquitin like modifiers and their enzymatic components.
Research areas: Programmed cell death, necroptosis, inflammation, post-injury tissue regeneration, chemotherapeutics-induced cell death
Dr. Liming Sun is a Professor at the Center for Excellence in Molecular Cell Science of Chinese Academy of Sciences. She completed her PhD in 2009 at National Institute of Biological Science in Beijing and completed postdoc training (2009-2014) at UT Southwestern Medical Center in Dallas. Her research is primarily focused on the molecular mechanism of necrosis signaling, and its relevance to human diseases. Her work has led to a detailed understanding of the role of RIP3 phosphorylation activity in the necroptosis pathway. Among her major scientific contributions are the identification of a critical substrate of RIP3, mixed lineage kinase domain like protein (MLKL), and discovery of a new necroptosis inhibitor, NSA. Recent work from the Sun Lab has also identified a key role for necroptosis in promoting muscle stem cell proliferation after injury, thereby facilitating muscle regeneration.
Ecology & Evolution
Research areas: Paleobiology, macroecology & evolution
Dr. Katie Davis is a Lecturer and Researcher at the University of York (UK), based in the Leverhulme Centre for Anthropocene Biodiversity. She is a numerical evolutionary palaeobiologist and her research operates at the interface of Earth and Life Sciences. She is particularly interested in the effects of past climate change on life on Earth and how we can use the geological record to understand, and predict, the effects of present day climate change on the biota. She obtained her BSc in Geology from the University of Edinburgh, followed by a MSc in Palaeobiology at the University of Bristol. She completed her PhD in phylogenetics and evolutionary biology at the University of Glasgow. After a four year career break she returned to academia as a Research Associate at the University of Bath working on arthropod phylogeny and macroevolution. She joined the University of York in 2016.
Research areas: Ecology, ecosystem services, biological control, ecotoxicology, community ecology, integrated pest management, invasive species, sublethal effects of pesticides
Nico received his PhD degree in behavioral biology and ecotoxicology from the University of Paris XI. He subsequently hold a position of research associate in the US for several years working in the field of conservation and classical biological control, as well as on the ecology of invasive species and their natural enemies. He joined the National Research Institute for Agriculture Food and Environment in Sophia-Antipolis (INRAE) in France in 2008 as research associate, and now he is Research Director and head of the lab Community Ecology in Agroecosystems in this institute. Nico has a solid appreciation in insect ecology and agricultural systems and his scientific interests cover the fields of community ecology, classical and conservation biological control, ecotoxicology as well as ecosystem services. Additionally, he is strongly involved in research projects aiming to assess side effects of pesticides such as sublethal effects on natural enemies and pollinators, and more broadly on ecosystem services.
Research areas: Marine phytoplankton eco-physiology, ocean acidification, trace metals
Dr. Linn Hoffmann is a Lecturer for Marine Botany at the University of Otago New Zealand. Dr. Hoffmann completed her PhD in marine biogeochemistry at the University of Kiel (Germany). After postdoctoral stays in Gothenburg (Sweden) and Dunedin (New Zealand) she became the head of an Emmy Noether Young investigator group in Kiel (Germany) in 2013. In 2014 she became a Lecturer at the University of Otago, New Zealand. In the same year Linn was awarded the Feodor Lynen Fellowship by the Alexander von Humboldt foundation. Linn’s work concentrates on the implications of environmental stressors on marine phytoplankton ecology and physiology. She has a special interest in the effects of ocean acidification and trace metal release from volcanic eruptions on marine phytoplankton communities.
Research areas: ancient DNA, population genetics, bioinformatics
Her research focuses on ancient DNA extracted from human skeletal remains in order to study ancient societies, their practices and their development over time. She is a trained anthropologist, geneticist, and archaeologist. She obtained her PhD in Mainz, Germany, generating up to 10,000 years old ancient human genomes and contributing to resolving longstanding questions of Neolithisation in Europe and the Middle East. She received a Long Term EMBO Fellowship to cross disciplinary boundaries to focus on computational methods that integrate out genotype uncertainties of ancient DNA data for direct inference of demographic parameters of interest. Currently, she is Group Leader at Max Planck Institute for Evolutionary Anthropology and she also leads a team at the Department of Archaeology and Museology, Masaryk University Brno. Many of her current projects focus on the recent past, namely on integrating archaeology, genetics and history of the Migration Period and Early Middle Ages using a high number of samples allowing for inference of large-scale pedigrees and ethical and interdisciplinary interpretation of patterns of genetic relatedness.
Research areas: Animal behaviour, animal cognition, ecology, sensory biology, sensory ecology
Dr. Holland's research interests fall broadly in the area of animal behaviour and sensory biology. His research questions focus the cognitive processes and sensory mechanisms by which animals navigate and migrate. While his principle focus is at the level of the whole organism he also incorporates aspects of neurobiology, molecular biology, and physics to identify the environmental cues, sensory pathways and mechanisms used by animals to decide how, when and where to move. His work also operates in a comparative framework as he compares and contrasts across species, taxa, age class, spatial scale and sensory mechanisms to reveal how natural selection has acted to shape navigation behaviour in different animal groups.
Research areas: Climate change biology, biogeography, spatial ecology, phylogenetics, paleontology
Dr. Michelle Lawing is an Associate Professor in the Department of Ecology and Conservation Biology at Texas A&M University. Dr. Lawing received a dual major Ph.D. in Evolution, Ecology, and Behavior and in Geological Sciences from Indiana University in 2012. She completed postdoctoral work at the National Institute for Mathematical and Biological Synthesis at the University of Tennessee, Knoxville in 2013 and joined Texas A&M University as an Assistant Professor in 2014. At Texas A&M University, Dr. Lawing is principal investigator of the Paleobiology, Evolution, and Climate Lab. Dr. Lawing's research program addresses the critical challenge of predicting biotic responses to environmental change with the goal of informing practices that will mitigate loss of ecosystem health and biodiversity. To approach this challenge, her lab develops and applies novel quantitative methods that integrate paleontological and modern data. These methods help researchers answer fundamental ecological and evolutionary questions related to the multifaceted mechanisms responsible for changes in species' morphology, geography, and community through time.
Research areas: Plant ecology, population ecology, quantitative ecology, disease ecology
Dr. Shouli Li is a Professor in Ecology & Biodiversity at Lanzhou University, China. She is a plant ecologist. Her research focuses on population ecology and environmental decision-making in the areas of ecological restoration, biodiversity conservation, invasive species management and optimal control of infectious disease.
Dr. Li received her PhD in Plant Ecology & Biodiversity from Utrecht University, The Netherlands. She then moved to Finland (University of Turku) and United States (the Pennsylvania State University) for her postdoctoral training. In 2019, she moved back to China to establish her own research group at Lanzhou University. She is currently working on the effects of climate change on plant demography and biodiversity dynamics on Tibetan Plateau. She is an elected committee member and the secretary general of China Grassland Ecology Society.
Research areas: Theoretical ecology, behavioral self-organization, marine ecology
Dr. Quan-Xing is a Professor in the school of ecological and environmental sciences at East China Normal University, where he leads the self-organized behaviors of microorganisms and ecosystems group. After receiving his PhD in Theoretical Ecology from the University of Groningen (NL), he moved to the University of Amsterdam for him postdoctoral training in phytoplankton ecology at IBED. In 2015, he joined the Faculty at East China Normal University. Quan-Xing is interested in the emergent behaviors of the microorganisms and ecosystems that are driven out of equilibrium by an external drive, internal activity or local interactions. He use theoretical models to investigate the dynamics behaviors of the ecological and biological systems, from mesoscopic matter to microalga suspensions, and from the individual organisms to population/ecosystem levels patterns.
Research areas: Evolutionary biology, genetics/genomics of adaptation and speciation
Dr. Luciano Matzkin is currently an Associate Professor in the Department of Entomology, BIO5 Institute and the Department of Ecology and Evolutionary Biology at the University of Arizona. Dr. Matzkin received his PhD from the Department of Ecology and Evolution at Stony Brook University. He was a PERT Postdoctoral Fellow in the Department of Ecology and Evolutionary Biology at the University of Arizona and then became a Research Scientist in the Division of Biological Sciences at the University of California San Diego. Prior to moving back to Arizona, he was an Assistant Professor in the Department of Biological Sciences at the University of Alabama in Huntsville. His work has focused on understanding the genetic/genomic basis of adaptation as well as investigating the evolution of reproductive incompatibilities. His research group takes a multifaceted approach examining patterns of variation at the gene, genome, organismal, life history and behavioral level as well as performing manipulative experiments utilizing a number of cactophilic Drosophila species.
Research areas: Evolutionary biology, comparative phylogenetics, behavioural ecology, adaptation, species traits
Dr. Nandini Rajamani is Assistant Professor in the Biology Department at the Indian Institute of Science Education and Research Tirupati (IISER Tirupati), located in South India. Her research interests include understanding adaptations and dynamics of small mammal populations, particularly with respect to evolutionary and environmental (eg. climate-change and human-altered landscapes) factors. She has long-term field research projects in the Indian Trans-Himalayas, and in the Western and Eastern Ghat mountains in southern India. In both landscapes she uses a combination of field research, genomics and modelling to understand species behaviour and predict response to local and global changes. She obtained her BA in Economics from the University of Madras, followed by an MS in Ecology at Pondicherry University. She then went on to obtain a PhD in Evolutionary Biology from Auburn University, studying the evolution of gliding and body size in flying squirrels. Following a two-year post-doctoral experience, she worked with science communication and administration for three years, working to create a platform for professional biology across India. She returned to academia in 2016, but her career continues to reflect her two interests — conducting research and communicating science.
Research areas: Marine Ecology, Kelp Forest Biology, Fisheries, Marine Heatwaves, Marine Conservation Biology
Dr. Laura Rogers-Bennett is a Research Associate with the Karen C. Drayer Wildlife Health Center at the University of California, Davis and a Senior Environmental Scientist, Specialist with the California Department of Fish and Wildlife. She is based at the Bodega Marine Lab where she leads a team investigating marine ecosystem health and fishery management and marine conservation in a changing ocean climate. To do this work they use an interdisciplinary approach combining scuba, field, laboratory and quantitative modeling to examine questions related to wildlife health, ecosystem tipping points, marine conservation biology, fisheries sustainability and climate change. Dr. Rogers-Bennett has authored over 60 scientific publications and 10 book chapters. She has research focused on climate change, marine heatwaves, kelp forest monitoring, sustainable fisheries and abalone conservation.
Research areas: Invasive species; Endosymbionts, Wolbachia; Insect Vectors; Biological control; Integrated Pest Management
Dr. Schuler is an Assistant Professor in Agricultural and Forest Entomology at the Free University of Bozen-Bolzano in Italy. He received his undergraduate degree in Agriculture and Phytomedicine from the University of Natural Resources and Life Sciences, Boku, Austria where he also completed his Ph.D. Schuler was a Postdoctoral Fellow at Boku Vienna, the Free University of Bozen-Bolzano and the University of Notre Dame. In 2018 he joined the Free University of Bozen-Bolzano as an Assistant Professor. Schuler’s research focuses on the association of microbes with insects and their impact on the ecology and evolution of their hosts, the invasion dynamics of invasive insect species, and factors influencing the efficiency of vectors of plant diseases. These research projects are addressed by a combination of genomic and population genomic approaches as well as in vivo experiments in laboratory and semi-field experiments.
Genetics & Development
Research areas: Reproductive biology, seminal fluid protein biology, sperm storage, sperm competition
Dr. Frank Avila is a Max Planck Tandem Group Leader at the University of Antioquia in Medellín, Colombia. He received his PhD in genetics at Columbia University where he studied the regulation of the Drosophila sex-determination gene sex-lethal. Dr. Avila did his post-doctoral training at Cornell University, examining the role of male seminal fluid proteins in female fertility of Drosophila. It was during his time at Cornell that he became interested in the fertility of Aedes mosquito vectors. Dr. Avila established his lab at the University of Antioquia in 2016, with a focus on the identification and characterization of male- and female-specific molecules required for optimal fertility in the dengue vector mosquito Aedes aegypti. Dr. Avila’s long-term goals include understanding how male and female contributions ensure the optimal fertility of a mating pair, and how these molecules can be targeted to suppress mosquito fertility and, by extension, the diseases they spread.
Research areas: Statistical genetics, bioinformatics, neurogenetics, repeat expansion disorders
Professor Melanie Bahlo leads the statistical genetics laboratory at the Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia. She has over 20 years experience in developing new analysis methods as well as leading bioinformatics teams to investigate the genetic risk factors in neurological, retinal disorders and infectious diseases. Current research interests in the Bahlo lab include repeat expansion detection, RNA editing, GWAS, Mendelian Randomisation, short and long-read next-generation sequencing data analysis and applications of these methods to diseases of interests.
Research areas: Mouse genetics, pancreatic islet biology, cellular plasticity, cell fate, development, regeneration
Simona obtained her PhD from the Department of Genetics and Evolution, at the Faculty of Science, University of Geneva, in 2008, with a focus on cellular and molecular mechanisms of regeneration. As a postdoctoral fellow in Prof. Pedro Herrera lab, she was involved in the characterization of two age-dependent regenerative mechanisms governing spontaneous murine pancreatic β-cell regeneration. Simona is now an Associate Professor at the Department of Clinical Science, University of Bergen and an Young Associate Investigator to the Norwegian Center for Molecular Medicine, part of Nordic EMBL Partnership for Molecular Medicine.
The main focus throughout her career has been the characterization of the cellular processes and molecular cues regulating the balance between tissue regeneration and homeostasis. Currently, her research is directed at how cell death features govern the type of regenerative strategy employed by a biological system. By coupling classical and newly generated models of cell loss with genetic cell tracing, timed conditional gene expression and omics assays (transcriptomics, proteomics, scRNAseq), her lab investigates the dynamic molecular fingerprint of pancreatic islet cells decay and regeneration, with focus on self-renewal and global regulators of cell identity maintenance processes.
Research areas: Human genetics, complex traits and disorders, genome-wide association studies, whole-genome sequencing, genetic instrumental variable studies, admixture studies and fine-mapping, tools for post-GWAS annotation and functional interpretation.
Dr. Hélène Choquet is a Research Scientist at the Kaiser Permanente Northern California, Division of Research. Dr. Choquet completed her Ph.D. in Human Genetics from the Lille 2 University of Health and Law in France. Prior to joining the faculty at the Kaiser Permanente Northern California Division of Research, she was a Postdoctoral Research Fellow at the University of California, San Francisco in the Department of Neurology and in the Department of Anesthesia & Perioperative Care, where she was a recipient of an American Heart Association award. Dr. Choquet has broad expertise in Human Genetics, having worked on diverse complex traits and disorders, including obesity, alcohol and tobacco use, brain vascular malformation, skin cancer, and vision disorders.
Research areas: Functional genomics and metagenomics; RNA editing; viral pathogen evolution; big (omics) data analytics
Dr. Pei Hao is a Professor in Institut Pasteur of Shanghai, Chinese Academy of Sciences (CAS), and the Principle Investigator for the Group of Pathogen Big Data. She obtained her PhD degree in Bioinformatics from Fudan University, Shanghai, China. Before she joined Institut Pasteur of Shanghai, she was an associate professor in the Key Laboratory of Systems Biology, CAS. Dr. Hao has been focused on bioinformatics and systems biology research in algorithms development and data-mining methodology. Over the years, her team made significant contribution to the pathogen discovery of SARS-CoV-1, H7N9 Influenza A, SARS-CoV-2, etc. She advanced functional RNA editome research by revealing the roles of RNA editing in genetic evolution and pathogen-host interactions. Dr. Hao is the receiver of the First Prize of Shanghai Natural Science Award, the Chinese Academy Lu Jiaxi Young Scholar Award, and the Chinese Academy SIBS Sanofi-Aventis Award.
Research areas: Cardiovascular Medicine, Genetics and Genomics, Biostatistics, Machine Learning, Multi-Omics Data Analysis
Dr. Kaoru Ito is a team leader at the RIKEN Center for Integrative Medical Sciences in Yokohama, Japan. His group seeks to understand the genetic underpinnings of cardiovascular diseases in terms of both population genetics and Mendelian disorders. Dr. Ito's group is working on analysis methods, such as an application of artificial intelligence and multi-omics data to solve the ""P greater than N” scenario, where the sample size is small, but the number of variants to be analyzed is large, and an integrated disease risk scoring system for clinical use. Dr. Ito and colleagues are also developing a system to prioritize variants of unknown function using massively parallel in vitro assays. Finally, his ultimate goal is to translate the results of such basic research into clinical practice.
Chiea Chuen Khor
Research areas: Ophthalmology, pathogenesis of human disease, genome-wide association studies, whole exome and whole genome sequencing
Dr. Chiea Chuen Khor leads the Laboratory for Complex Disease Genetics at the Genome Institute of Singapore. He hold concurrent appointments as an Adjunct Professor at the Duke-NUS Medical School and an Adjunct Clinician Scientist at the Singapore Eye Research Institute. His group works on genetic susceptibility to common human diseases (with a special emphasis on ophthalmology) using genome-wide association studies, whole exome, and whole genome sequencing. He particularly enjoys reading about the rich yield and biological insights provided by large-scale genome-wide association studies in understanding the pathogenesis of human diseases. Moving forward, he hopes to study the impact of rare coding-sequence genetic variation in common diseases to see if additional insights missed by genome-wide scans can be learnt.
Chiea Chuen qualified in medicine from the National University of Singapore, and completed a D.Phil in genetics at the Wellcome Trust Center of Human Genetics at Oxford. His post-doctoral work was undertaken in the laboratory of Dr. Martin Hibberd (then at the Genome Institute of Singapore) where he helped perform genome-wide association studies for infectious and inflammatory diseases such as Kawasaki disease, Meningococcal disease, and Dengue shock syndrome. He was a recipient of the EMBO Young Investigator award in 2015.
Research areas: Mendelian randomisation, thyroid function and cancer, machine learning, disease prediction
Dr Eirini Marouli is a Lecturer in Computational Biology at the William Harvey Research Institute, Queen Mary University of London. Dr Marouli’s research interests lie in the interface of genetics, machine learning and bioinformatics, in order to achieve a better understanding of human biology and disease prediction with the use of “Big Data”. Dr Marouli has a leading role in the large international consortium, GIANT, that has discovered almost all of the genetic variants that are known to influence human height and obesity related traits. Dr Marouli has also a leading work and contributions in global consortia (GLGC, CHARGE CARDIoGRAMplusC4D) for complex traits and diseases. In addition to gene discovery efforts, Dr Marouli is also interested in genetic-epigenetic approaches to complex phenotypes. Dr Marouli specialises on Mendelian Randomisation and causal inference and is a co-convener of the Mendelian Randomisation working group within GIANT consortium. Dr Marouli’s research is also focusing on thyroid function and disease in collaboration with ThyroidOmics consortium. Dr Marouli is passionate about applications of Artificial Intelligence for disease prediction.
Research areas: Developmental biology, hox genes, embryonic patterning, mouse genetics, neuromesodermal progenitor
Edwina is a developmental biologist, working to elucidate novel gene regulatory networks driving growth and patterning of the early vertebrate embryo. She is fascinated by just how robust developmental networks are for a single species, yet plastic enough to enable the vast morphological diveristy we see across the vertebrates. By combining complex mouse genetics, genomics and imaging, her lab is tackling numerous developmental questions; How are the genetic networks controlling primary body axis length integrated with those that impart positional identity; How are sensory relay neurons specified and arranged topographically within neural circuits? Much of her work centres on Hox gene networks — What acts upstream to coordinate colinear Hox activation and what acts downstream to pattern the embryo. Her lab is constantly evolving with the rapidly advancing genomic technologies, and utlises parallel in vitro and in vivo approaches to allow them to capitalize on the breadth of these technologies.
Research areas: Epigenetics, genomics, chromatin, transcription, early embryonic development, stem cells
Dr. Patrick Murphy is currently an independent investigator at the University of Rochester where he holds the title of Assistant Professor with joint appointment in the Departments of Biomedical Genetics and Biology. Dr. Murphy received his Ph.D. from Cornell University where he worked with Dr. Paul Soloway to investigate mechanisms of imprinted DNA methylation in mouse, and helped to develop single molecule epigenomics analysis methods. He carried out his postdoctoral research in the laboratory of Bradley Cairns at the Huntsman Cancer Institute, where he studied epigenetic reprogramming and non-genetic inheritance in zebrafish. He also worked extensively with the Utah Center for Reproductive Medicine to investigate mechanisms by which the environment influences epigenetic marks in mammals. Prior to his Ph.D. studies Dr. Murphy worked with Dr. Elissa Lei at the NIDDK investigating chromatin insulators in Drosophila. The Murphy lab currently investigates how epigenetic mechanisms activate and/or silence genes as cells transition from one state to another. Their work relies heavily on genetics, genomics, and functional bioinformatics methods, which they apply to cell culture systems and zebrafish embryos during early development.
Research areas: Tissue regeneration, stem cell regulation, planarian biology, bioelectric regulation of stem cells, tissue renewal
Dr. Néstor J. Oviedo is the Vice-Chair of the Department of Molecular and Cell Biology at the University of California, Merced. His lab studies underlying mechanisms of stem cell regulation during tissue regeneration and cellular turnover using planarian flatworms as a model organism. Research in the Oviedo lab is multidisciplinary, involving aspects of cell biology, genetics, development, and the innate immune system. The main lines of research in his lab include DNA damage/repair, host-pathogen interactions during fungal infections, bioelectric regulation of stem cell behavior, and links between tissue repair and cellular transformation.
Jun Wei Pek
Research areas: Germline, RNA, stem cells, Drosophila, regulation of gene expression
Jun Wei Pek is a Principal Investigator at the Temasek Life Sciences Laboratory (TLL) in Singapore. He received his B.Sc. (Hons) and Ph.D. from the National University of Singapore (NUS). His graduate research focused on the roles of nuage and small RNAs in the Drosophila germline. This was followed by a postdoctoral training at the Carnegie Institution for Science (Department of Embryology) where he began to explore a novel class of long noncoding RNAs called stable intronic sequence RNAs or sisRNAs in Drosophila. He was later named a Howard Hughes Medical Institute (HHMI) Fellow of the Life Sciences Research Foundation. Currently, his laboratory is interested in investigating the molecular and biological functions of sisRNAs, and their roles in cancer.
Mireya Plass Pórtulas
Research areas: single-cell transcriptomics, alternative polyadenylation, post-transcriptional regulation, RNA binding proteins
Dr. Mireya Plass is a group leader at the Regenerative Medicine Program from the Bellvitge Biomedical Research Center (IDIBELL) and at the Program for Advancing Clinical Translation of Regenerative Medicine of Catalonia, P-CMR[C]. She received her PhD in Health and Life Sciences from Pompeu Fabra University in Barcelona, Spain. She pursued postdoctoral training abroad at the University of Copenhagen (2011-2015) and at the Berlin Institute for Medical Systems Biology (2016-2019) before returning to Spain to complete her post-doctoral training at the Center for Genomic Regulation with a Marie Sklodowska-Curie Fellowship. At the end of 2019, she joined CMRB (now P-CMR[C] & IDIBELL) as independent group leader and shortly after she was awarded a Ramón y Cajal contract from MINECO to support her position as principal investigator. Throughout her career, Dr. Plass has been interested in understanding how post-transcriptional regulatory mechanisms shape gene expression from an evolutionary and systems biology perspective. As independent group leader, her lab investigates the function of post-transcriptional regulation in gene expression and cell differentiation and their contribution to the development of neurodegenerative diseases using a combination of high-throughput and single-cell transcriptomics, computational methods and experimental approaches.
Research areas: Single cell genomics, computational biology, machine learning, big data
Debarka is an assistant professor of the departments of Computational Biology and Computer Science at IIIT-Delhi. Debarka did his doctoral research at the Machine Intelligence Unit of the Indian Statistical Institute. After graduation in 2013, he pursued his postdoctoral research at the Genome Institute of Singapore, where he got exposed to the then-emerging field of single-cell genomics. In the past few years, his research group at IIIT-Delhi has published several breakthrough findings in the single-cell genomics space, including the discovery of a rare subtype of pars tuberalis lineage in mouse brain (Jindal et al., Nature Communications, 2018). His current research focuses on transcriptional homeostasis, early cancer detection using liquid biopsy techniques, and functional interpretation of human variants. He is a recipient of the prestigious INSPIRE Faculty Award. Debarka also serves in the editorial boards of PLOS One and Scientific Reports.
Research areas: Hematopoietic stem cells, regeneration, development, innate immune signalling, transcription factors
Dr. Eirini Trompouki is a group leader at the Max Planck Institute of Immunobiology and Epigenetics in Germany. She performed her graduate studies in B.S.R.C. “Al. Fleming” where she focused on identifying novel regulators of the NF-κB pathway. Having obtained a Jane Coffin Childs Memorial Fund fellowship, she joined the lab of Leonard Zon in Boston Children's Hospital and embarked on the molecular mechanisms that govern hematopoietic stem cell differentiation towards erythrocytes. During this work she discovered how lineage determining transcription factors guide signal-induced transcription factors to specific genomic regions, thus achieving tissue specificity of signaling. In her own group at the Max Planck Institute of Immunobiology and Epigenetics, they study hematopoietic stem cell formation during development and hematopoietic regeneration in adults with an emphasis on the molecular mechanisms that regulate these processes. Dr. Trompouki is interested in the role of transcription factors, innate immune signaling and repetitive elements in hematopoiesis. In 2019, she received the ZDMS Junior faculty award of excellence from the Zebrafish Disease Models society for the dissection of the metabolic regulation of normal and malignant hematopoiesis by transcription factors.
Immunology & Infectious Disease
Research areas: Innate immunity, apoptosis, pyroptosis, NETosis, bacterial infection
Dr Kaiwen Chen is an Assistant Professor at the National University of Singapore. Kaiwen obtained his PhD in 2015 from the University of Queensland, Australia, for characterising the role of neutrophil inflammasomes during microbial infection. In 2018, Kaiwen relocated to the University of Lausanne, Switzerland, for his postdoctoral training where he characterised the role of gasdermin pore-forming proteins during bacterial infection. His current research focuses on understanding the complex crosstalk between innate immune signalling and cell death pathways including apoptosis, pyroptosis and NETosis, with the aim of rewiring these processes to treat infectious and inflammatory diseases.
Research areas: Nucleic acid vaccines, antivirals, SARS-CoV-2, influenza, HIV, ZIKV, HBV
Dr. Deborah Fuller is a Professor in the Department of Microbiology at the University of Washington School of Medicine and Chief of the Infectious Diseases and Translational Medicine Division at the Washington National Primate Research Center. Prior to her academic career, Dr. Fuller worked in biotechnology developing vaccines against HIV, HBV and emerging infectious diseases. In 2004, she transitioned to academia where she is leading a team developing nucleic acid vaccine platform technologies and investigating immune mechanisms of protection and pathogenesis of viral infections. She recently developed a vaccine for COVID-19 that is scheduled to enter human clinical trials in Fall 2020. Dr. Fuller is a co-founder of a biotechnology company, Orlance, Inc (www.orlance.com) that aims to advance nucleic acid vaccines to clinical testing. She is currently a member of the National Institute of Allergy and Infectious Diseases (NIAID) Vaccines for Microbial Diseases (VMD) study section and serving on the leadership team for the Nonhuman Primate COVID Vaccines and Therapeutics Evaluation Network to accelerate the development of promising COVID-19 vaccines and antivirals. She has led translation of two vaccines from bench to clinical trials, authored 80 manuscripts and is a co-inventor on over a dozen patents for vaccines and antivirals.
Research areas: Immunoregulation, tolerance, regulatory T cells, cellular therapy
Joanna is a University Research Lecturer at the University of Oxford and jointly leads the Transplantation Research and Immunology Group at the Nuffield Department of Surgical Sciences. She holds an MSc in Biotechnology and PhD in Immunology from the Medical University of Gdansk, Poland. After her PhD, she moved to the UK for a postdoctoral position at the University of Oxford. In 2014, she was awarded the Kidney Research UK Senior Fellowship. Her research focuses on understanding the mechanisms of immunological tolerance versus immune activation with a view to developing therapies that could benefit patients with immune related diseases. She is particularly interested in immune cells with regulatory properties, regulatory T cells and myeloid-derived suppressor cells and the molecular mechanisms of suppression utilized by these cells.
Research areas: innate immunity, virology, virus-host interactions, NF-kB, interferon
Dr. Li is an Associate Professor at Tulane University, New Orleans, LA, USA. He received a Ph.D. from Wuhan University in 2000. Then, he completed his post-doctoral studies at Harvard Medical School, Boston, investigating NF-kB signaling and antiviral innate immunity. His current research focuses on understanding the mechanisms of nucleic acid-mediated innate immune signaling pathways and the role of these signaling pathways in infectious diseases, autoimmune disease, and tumorigenesis. His lab is also interested in mapping virus-host interaction networks and how these interactions modulate host defense and viral pathogenesis.
Si Ming Man
Research areas: Microbiology, innate immunity, chronic disease
Dr. Si Ming Man received his Ph.D. from the University of Cambridge, United Kingdom, for his work on inflammasomes in the host defence against Salmonella infection. He conducted his postdoctoral training at St. Jude Children’s Research Hospital, USA, where he investigated the role of inflammasome signalling in the host response to infection and cancer. Currently, he is a Group Leader at the Australian National University, Australia, where his laboratory focuses on innate immunity in the host defence against infectious diseases and the development of cancer and other chronic diseases.
Research areas: Host-microbiome relationships, orphan nuclear receptors, inflammation, cancer
Prof. Sridhar Mani is currently a Tenure-Track Professor at The Albert Einstein College of Medicine, Bronx, NY in the Departments of Medicine, Molecular Pharmacology, and Genetics. Prof. Mani received his M.D (Alpha Omega Alpha) Icahn School of Medicine at Mount Sinai, New York. After a residency in Internal Medicine and Oncology at the Yale-New Haven Hospital, he completed a postdoctoral fellowship investigating tumor suppressor genes in the laboratory of Eric Fearon at Yale University. His current focuses on the study (molecular and translational biology) of orphan nuclear receptors as it relates to drug metabolism and immunity. More recently, with the discovery of bacterial metabolites that may serve as ligands for the Pregnane X receptor (PXR), the laboratory has focused its efforts on the role of microbial metabolites in dictating host physiology and immunity.
Lim Theam Soon
Research areas: Antibody phage display, antibody gene usage, diagnostics, immunotherapy, molecular biology
Dr Lim Theam Soon is an Associate Professor at Universiti Sains Malaysia. His doctoral thesis on antibody phage display was conducted at Max Planck Institute for Molecular Genetics where he graduated with a Dr.rer.nat in Molecular Biology from Freie Universitat Berlin. He was a recipient of the International Society of Infectious Diseases Research Grant for early career researchers. Dr Lim’s research focus is on the design and characterisation of human antibodies against various target antigens. His team also develops naïve and immune human antibody libraries for diagnostics and therapeutic applications. His research group also develops molecular methods to initiate mutagenesis for molecular evolution. Dr Lim’s current work focuses on the relationship of antibody gene usage in infectious diseases.
Google Scholar profile
Research areas: Adaptive immunity, allergy, cancer immunology
Damon received a Ph.D. in immunology from the University of Adelaide in 2009. He then did his post-doctoral studies at Chiba University Medical School, Japan, investigating epigenetic mechanisms regulation of T cell differentiation. His main research interests are lymphocyte differentiation and immunological memory in the context of chronic allergic inflammation. Damon is now a lab head at the University of South Australia and SA Pathology Centre for Cancer Biology in Adelaide. He is continuing to study airway inflammation and also applying his experience working on lymphocyte differentiation and function to cancer immunology. Damon also has additional faculty appointments at both the South Australian Health and Medical Research Institute and Chiba University.
Research areas: Microbial metagenomics, multi-omics integration, microbial ecology
Dr. Anna Heintz-Buschart is a scientist at the Helmholtz-Centre for Environmental Research (UFZ) in Halle, Germany and heads the Metagenomics Support Unit of the German Centre for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig. She is passionate about understanding microbial diversity and about the conservation of biodiversity. She studied biology with a focus on microbiology and received her PhD in Natural Sciences from the Technical University in Braunschweig, Germany, in 2011 for work on antifungals in Candida albicans. During a postdoc at the Luxembourg Centre for Systems-Biomedicine, she focused on the integration of multiple meta’omics levels in the human microbiome and in the microbial communities of waste water treatment plants. Her current work has allowed her to study a wide range of microbial communities, from soil and plant-soil systems, over deadwood, to animal- and human-associated microbiomes, using analysis and integration methods, including classical statistics, network analyses, and machine learning, on data from diverse bio-analytical approaches, from meta-barcoding and metagenomics, to transcriptomics and metabolomics.
Research areas: Intracellular parasitism, parasite metabolism & signaling, optogenetics in pathogens
Dr. Nishith Gupta completed his undergraduate studies in Biology (1994-97) and Master in Biotechnology (1997-99) from India. He received his PhD degree in Biochemistry from the University of Leipzig, Germany (1999-2003), and then undertook a postdoctoral training in parasite membrane biology at National Jewish Medical Research Center (Denver, United States; 2003-2006). Afterwards, he joined Humboldt University of Berlin, Germany as a research associate (2006-2009), and later established his independent group. In 2016, he was appointed as a Heisenberg Group Leader, and soon after in 2017, Dr. Gupta was awarded a Habilitation degree with Venia Legendi (eq. DSc) in Biochemistry from Humboldt University of Berlin. A particular feature of his profile is that he has been broadly trained in biochemistry, genome engineering and cell biology of pathogenic protists. The major foci of his work have been to examine the membrane dynamics, metabolism and signaling in single-cell intracellular parasites with respect to their pathogenesis, persistence and adaptation in mammalian host cells. Well over a decade of independent work, his group has successfully unified the core biological disciplines with optogenetics and multi-omics.
Research areas: Microbiology, microbial biotechnology, microbial metabolism and physiology
Dr. Calvin A. Henard is an Assistant Professor in Department of Biological Sciences and the BioDiscovery Institute at the University of North Texas. Dr. Henard completed his Ph.D. in Microbiology from the University of Colorado Anschutz Medical Campus in Aurora, Colorado. Prior to joining the faculty at UNT, he was a postdoctoral scholar at the University of Texas Medical Branch and a staff scientist at the National Renewable Energy Laboratory's National Bioenergy Center. Dr. Henard has broad expertise in microbiology, having worked with diverse microorganisms, including bacterial and protozoan pathogens, and non-model yeast, bacteria, and microalga. Currently, his laboratory investigates methanotrophic bacterial metabolism and physiology to guide the development of biotechnologies for the conversion of one-carbon substrates to fuels and chemicals using these unique bacteria.
Research areas: Microbial ecology, genomics, microbial metabolic activity
Prof Thulani Makhalanyane is an Associate Professor in the Department of Biochemistry, Genetics and Microbiology at University of Pretoria. He earned his doctoral degree at the University of the Western Cape in 2013.
His scientific interests focus primarily on fundamental questions in the field of microbial ecology, genomics, and microbial metabolic activity. Understanding microbial community dynamics in natural systems is a central goal of his research. His current research spans across ecologically extreme terrestrial and marine environments.
Research areas: Mycology, fungal ecology, microscopy
Dr. Meritxell Riquelme is head of the Department of Microbiology at the Center for Scientific Research and Higher Education of Ensenada (CICESE) in Baja California, Mexico, where she has been on the faculty since 2004. After graduating in Biology from the University of Barcelona, in Spain, she received a MSc degree in Plant Pathology and a PhD in Microbiology at the University of California, Riverside. She then moved to the University of Oxford, United Kingdom, as a postdoctoral fellow to study the receptor and pheromone mating type genes of Coprinopsis cinerea. Dr. Riquelme combines advanced life microscopy techniques and molecular biology to study secretory routes of vesicles involved in the polar growth of hyphae of Neurospora crassa. She also studies the ecological distribution of Coccidioides, the fungus that causes Valley Fever, in semi-arid regions of Baja California. More recently she has explored the fungal diversity of deep-sea sediments of the Gulf of Mexico. She is a member of the Mexican Academy of Sciences. In 2018 she received the B. O. Dodge award for her contributions to the Neurospora research community.
Sine Lo Svenningsen
Research areas: gene regulatory mechanisms, riboregulation, tRNA, quorum sensing, microbial transcription and translation, bacteriophage-host interactions
Sine Lo Svenningsen is an Associate Professor at the Department of Biology, University of Copenhagen, Denmark since 2012. She began her training with Stanley Brown at the University of Copenhagen and Sankar Adhya at the National Institutes of Health, USA, did her PhD in Molecular Biology in the laboratory of Bonnie Bassler at Princeton University, and returned to UCPH as an assistant professor in 2010 after a short postdoctoral stay with Thien-Fah Mah at Ottawa University, Canada. Dr. Svenningsen studies the regulation of bacterial and bacteriophage gene expression with an emphasis on riboregulation, such as small-RNA-mediated regulatory mechanisms, and regulation of the RNA components of the translation machinery. Understanding the specific degradation of particular tRNA species in E. coli in response to stress, is a current focus of her lab. In addition, Dr. Svenningsen keenly studies phage-host interactions, in particular those governed by quorum sensing.
Research areas: Host-microbiome interactions, reproductive microbial ecology, microbiome and disease, microbiome and animal behavior
Dr. Kevin Theis is an Assistant Professor in the Department of Biochemistry, Microbiology, and Immunology within the Wayne State University School of Medicine. Dr. Theis received a dual major Ph.D. in Zoology and in Ecology, Evolutionary Biology, and Behavior from Michigan State University in 2008. He also completed his postdoctoral research at Michigan State University, studying the role of the scent gland microbiome in the chemical communication systems of spotted and striped hyenas. At Wayne State University, Dr. Theis has continued studying how microbiomes contribute to animals’ behavioral phenotypes and how animals’ socioecological circumstances structure their microbiomes. His current focus is on reproductive microbial ecology. Specifically, his lab is evaluating the sterility of the mammalian uterus and amniotic cavity, etiologies of intra-amniotic infection, and the role of the vaginal microbiome in spontaneous preterm birth. Since 2016, Dr. Theis has been the Head of the Maternal-Fetal Microbiome Unit of the Perinatology Research Branch of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
Research areas: Auditory cortex, sensory processing, Hippocampus, memory consolidation, sleep
Dr. Daniel Bendor is an Associate Professor in Behavioural Neuroscience at University College London. He received his PhD in Biomedical Engineering at Johns Hopkins University and conducted his postdoctoral research at MIT's Picower Institute. His research focuses on understanding the neuronal substrates of perception and memory. His lab uses combination of large-scale electrophysiological recording methods and molecular-genetic tools in behaving rodents to examine how information is encoded in the hippocampus and neocortex, and how these neural circuits are further modified during sleep to store long-term memories.
Research areas: EEG, human electrophysiology, brain stimulation, psychopharmacology, neuropsychiatric disorders, cognitive neuroscience
Christian Beste is Professor for Cognitive Neurophysiology at the TU Dresden. He graduated in psychology in 2006 and obtained his PhD in 2007. He was Post-Doc at several Institutes and Universities, including the Leibniz Research Centre for Working Environment and Human Factors (Dortmund), the Department of Clinical Radiology (Münster), and the Biopsychology Unit (Ruhr-Universität Bochum). In 2010 he was visiting scientist (DFG scholarship) at the MRC Cognition and Brain Science Unit (University of Cambridge, UK). In 2012 he established an independent research group (Emmy Noether Grant) at the Ruhr-Universität Bochum. In 2013, he became Professor at the TU Dresden, Medical Faculty. He holds an adjunct Professorship at the Faculty of Psychology (TU Dresden) and is affiliated with the Shandong Normal University, Department of Psychology, China. His interdisciplinary and multi-methodological research establishes links between cognitive theory and neurophysiology to elucidate human action control and disturbances in action control. The goal from a clinical point of view is to establish a multifactorial framework to explain the cognitive patho-neurophysiology of fronto-striatal networks.
Research areas: Neurobiology of pain, neuroinflammation
Thiago Cunha, PhD is Associate Professor of the Department of Pharmacology and of the Center for Research in Inflammatory Diseases (CRID) at the University of Sao Paulo, Ribeirao Preto, Brazil. He is currently the vice-president of Brazilian Society of Pharmacology and Experimental Therapeutics. His scientific career begun in the lab of Prof. Sergio Ferreira when he was undergrad student. From that time, he is dedicated to understand neuro-immune interactions involved in the development of pathological pain, specially inflammatory and neuropathic. Among the main contributions from his lab to the field of pain are the studies concerning the pronociceptive role of cytokines/chemokines and complement system. Based on these studies, his lab also participates in the development of novel CXCR1/2 and C5ar1 allosteric antagonist, which are in final steps of drug development. Among his honor related to the scientific career are the 2020 Patrick D. Wall Young Investigator Award for Basic Science awarded by IASP and World Academy of Science-TWAS-Lacrep prize for young investigators in the biological field.
Research areas: Attention, decision making, executive function, curiosity, neurophysiology
Jacqueline Gottlieb is Professor of Neuroscience in the Mortimer B. Zuckerman Institute for Mind Brain and Behavior at Columbia University, New York. She completed her undergraduate education in cognitive science at the Massachusetts Institute of Technology, her PhD in neurobiology at Yale University and her postdoctoral training at the National Institute of Health. Dr Gottlieb studies the neural mechanisms of decision making and executive function, with a particular interest in information seeking and curiosity.
Research areas: Neuromuscular disease Human iPSC-based models of neural circuits Optogenetics
Ivo joined King’s College London in 2009 after working on his PhD thesis on the immune response to a viral oncogene with Prof Klaus Rajewsky and Dr Irmgard Forster (University of Cologne, Germany) and as a postdoc with Prof Thomas Jessell (Columbia University, USA). In the Jessell group, he studied motor axon guidance and developed a method that allows the direct differentiation of motor neurons from ES cells together with Dr Hynek Wichterle. This approach has since become an important research tool for studying normal motor neurons development and motor neurons disease. The focus of his research over the past few years has been the question how stem cell technology can be harnessed to understand the function and dysfunction of neural circuits that control motor behaviour, and how stem cell-derived tissue can be used to regenerate neuromuscular circuits in adult mammalian animal models and, ultimately, in human patients. To this end, his group is undertaking projects aimed at i) assembling neuromuscular circuits from stem cell-derived, defined cell populations to study normal neural development and degenerative disease processes in vitro and ii) restoring motor function affected by spinal cord injury or Amyotrophic Lateral Sclerosis with human pluripotent stem cell-based neural graft.
Research areas: Functional MRI, multivariate pattern analysis, imaging analysis methods, power analysis, fMRI study design
Jeanette Mumford obtained her PhD in Biostatistics from the University of Michigan in 2006, with a focus on the analysis of functional magnetic resonance imaging (fMRI) data. She then began her career working with psychologists and neuroscientists using fMRI with the goal of using their unanswered questions to help develop new analysis strategies while helping to teach those scientists how to design efficient studies and work through complicated fMRI analysis pipelines. Her methods developments have focused on modeling strategies for fMRI, power analysis for fMRI and multivariate pattern analyses such as pattern similarity and pattern classification analyses. Her freely available educational resources on her MumfordBrainStats blog and YouTube channel, along with teaching at numerous fMRI analysis short courses earned her the Organization for Human Brain Mapping, Education in Neuroimaging Award in 2019. As of October 2020, she is a Research Scientist working with Russell Poldrack at the Department of Psychology at Stanford University.
Research areas: Genetics and Genomics, Neuroscience, Development
Dr. Alex Nord is an Associate Professor in the Center for Neuroscience at University of California, Davis. The goal of his research is to define the role and mechanisms of transcriptional regulation in the development, evolution, and disorders of the brain. Dynamic gene regulation underlies processes from patterning to cognition and is orchestrated by the interplay of regulatory DNA sequence (e.g. enhancers and promoters), transcription factors (TFs) and chromatin remodelers, and three-dimensional chromosomal interactions and epigenetic state. His lab integrates genetics and neuroscience, experimental and computational approaches, and in vitro and in vivo models to define the mechanisms of cis-regulatory transcriptional wiring in the brain.
Research areas: Cognitive neuroscience, behavioural neuroscience, computational cognitive science
Dr. Stefano Palminteri's main research topics are reinforcement learning and decision-making. More precisely he is interested in understanding the computational and neural bases underlying these processes, and whether and how biases in these processes could explain neuropsychiatric diseases and maladaptive behaviours.
Research areas: Neuroscience, neuron-glia interactions, gap junctions (connexins and pannexins), purinergic signaling.
Dr. Eliana Scemes is a Full Professor in the Department of Cell Biology and Anatomy of New York Medical College. She has a strong background in the field of Cellular and Molecular Neuroscience, particularly of astrocyte biology. Her research focuses on intercellular communication via gap junctions and purinergic receptors during brain development and under neuro-inflammatory and degenerative conditions. Her group uses a diversified set of approaches (imaging, electrophysiology, molecular biology, biochemistry, behavior) to asses in vitro, in situ and in vivo the role of gap junctions (connexins and pannexins) and P2 receptor. At present, the research projects deal with the contribution of pannexin to astrocyte and neuronal ATP signaling and its implications for seizures and neuropathic pain.
Research areas: Cognition; states of consciousness; computational modeling; dynamical systems; machine learning
Dr. Enzo Tagliazucchi obtained his PhD in neuroscience from the University of Frankfurt working on the neural correlates of consciousness across the human wake-sleep cycle. During his postdoctoral training at the Brain and Spine Institute in Paris, he investigated brain dynamics and structure-function relationships in patients with disorders of consciousness. He is currently tenured researcher at National Scientific and Technical Research Council (CONICET) and professor of physics at the University of Buenos Aires, Argentina, where he leads the Computational Cognitive Neuroscience Lab. His research focuses on the interplay between cognition and brain dynamics during different states of consciousness, combining neuroimaging experiments with the development of computational models.
Michel Thiebaut de Schotten
Research areas: Cognitive neuroscience, stroke, brain anatomy and evolution
Dr. Michel Thiebaut de Schotten received his PhD from la Sorbonne in Paris for his work on spatial neglect as a disconnection syndrome. As a postdoctoral researcher at the Institute of Psychiatry King's College London, he mapped the organisation of white matter anatomy in the healthy human living brain. Michel joined the French National Center for Scientific Research (CNRS) as a tenure- track researcher in 2012 and founded the BCBlab. He now conducts research on white matter anatomy, brain evolution, brain disconnections and new brain-behaviour associations. In 2014, he was awarded the prestigious British Neuropsychological Society's Early Career Award, the Elizabeth Warrington Prize as well as the European Society for Neuropsychology Cortex prize.
Research areas: Cellular and molecular neuroscience, Alzheimer’s disease, depression, synaptic transmission and plasticity.
Dr Christian Wozny received his doctorate at the Charité - Universitätsmedizin Berlin, Germany, and trained as a postdoctoral fellow at the Laboratory of Molecular Biology (MRC LMB) in Cambridge, UK, and at the Charité in Berlin. In 2015 he has started his own lab at the Strathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS) in Glasgow, UK. He is interested in studying neuronal diversity and microcircuits in health and disease using electrophysiology, anatomy and optogenetics. Christian also examines how neurons and synapses are regulated by neuromodulators, and how pharmacological compounds interact with synaptic receptors expressed in subsets of excitatory and inhibitory neurons.
Research areas: Brain imaging, cognitive neuroscience, machine learning, neurodegeneration and ageing
Dr. Juan (Helen) Zhou is an Associate Professor at the Center for Sleep and Cognition and the Deputy Director at the Center for Translational MR Research, Yong Loo Lin School of Medicine, National University of Singapore (NUS). She also holds a joint appointment with Neuroscience and Behavioral Disorders Program, Duke-NUS Medical School. Prior to joining NUS in 2011, Dr. Zhou was a post-doctoral fellow at the University of California, San Francisco and an associate research scientist at New York University. Her lab studies selective brain network-based vulnerability in neuropsychiatric disorders such as dementia and psychosis using multimodal neuroimaging and machine learning approaches.
Physiology & Metabolism
Research areas: Lipid mediators, G-protein coupled receptors, phagocytes, omega-3 supplements, arthritis, cardiovascular disease, bacterial infection, tissue repair, tissue regeneration
Jesmond Dalli is a Professor in Molecular Pharmacology at the Barts and The London School of Medicine and Dentistry and Queen Mary College. He is also a the director of the Lipid Mediator Unit at the William Harvey Research Institute. He received a B.Sc (Hons) in chemistry and biology and an M.Sc in biology from the University of Malta. He then read for and completed a Ph.D at the William Harvey Research Institute, Queen Mary University of London with Prof. Mauro Perretti. Prof. Dalli subsequently moved to Prof. Charles N. Serhan’s laboratory at Harvard Medical school and the Brigham and Women’s Hospital where he held a faculty post and was the co-director of two NIH funded lipid mediator profiling cores. His research efforts are focused on the structural elucidation of omega-3 polyunsaturated fatty acid-derived bioactive lipid mediators, assessing their cellular targets and the molecular mechanisms through which these mediators exert their actions in the resolution of inflammation. He has co-authored over 140 publications in peer-reviewed journals and holds several patents. He is also the co-founder of a Spinoff company that is developing resolution-based diagnostics.
Research areas: Aging, metabolism, adaptation
Dr. Christopher Hine is Assistant Staff in the Department of Cardiovascular and Metabolic Sciences at Cleveland Clinic Lerner Research Institute and Assistant Professor of Molecular Medicine at Cleveland Clinic Lerner College of Medicine. He earned his PhD in biochemistry from the University of Rochester School of Medicine and Dentistry under the guidance of Dr. Vera Gorbunova studying DNA repair and tumor suppression mechanisms using comparative biology approaches. He then performed postdoctoral studies in the Department of Genetics and Complex Diseases at the Harvard T.H. Chan School of Public Health in the lab of Dr. James R. Mitchell examining dietary and pharmacological interventions for improving surgical outcomes. He established his independent laboratory in 2016 and currently explores the gaps in scientific knowledge related to aging and investigates the application and mechanisms of anti-aging interventions. Specifically, his lab focuses on sulfur amino acid metabolism via the transsulfuration pathway and hydrogen sulfide production/metabolism as therapeutic targets for aging- and non-aging diseases alike.
Research areas: mitochondrial function, metabolic disease
Dr Kyle Hoehn is a metabolic biochemist and physiologist. He received a PhD in Biochemistry and Molecular Biology from Colorado State University in 2005 and completed postdoctoral training at the Garvan Institute of Medical Research in Sydney Australia in 2009. He has dual appointments as Assistant Professor of Pharmacology at the University of Virginia and Associate Professor of Biotechnology at the University of New South Wales. His research interests include small molecule drug discovery, mitochondrial function, and mouse models of metabolic disease.
Research areas: Cardiovascular disease modeling, circadian rythm
Dr. Tami Martino's research program is focused on translating fundamental knowledge about the circadian biology of the cardiovascular system into clinical applications. Her research team investigates how circadian dysregulation drives heart diseases, including myocardial infarction (heart attack), cardiac hypertrophy, and heart failure – our leading causes of death. They also examine how the heart’s circadian biology can be therapeutically manipulated to benefit how we heal from disease, using genetic, environmental or pharmacologic approaches to slow or reverse ongoing damage. This pioneering new field of medicine, termed Circadian Medicine, and will lead to longer and healthier lives. Dr. Martino is a Professor of Biomedical Sciences, Director of the Centre for Cardiovascular Investigations, and the Distinguished Chair in Molecular Cardiovascular Research at the University of Guelph. She is a Career Investigator of the Heart and Stroke Foundation of Canada in Circadian Medicine & Heart Health. Dr. Martino’s research is funded by the Canadian Institutes of Health Research, Heart and Stroke Foundation, and Canadian Foundation for Innovation.
Research areas: Mammalian nutrients metabolism, fat-soluble vitamins, chronic diseases
Dr. Loredana Quadro is a Professor of Food Science at Rutgers University (United States) and a member of the Rutgers Center for Lipid Research. After receiving her PhD in biotechnology from the University of Naples (Italy), she moved to the US for her postdoctoral training in nutritional biochemistry at Columbia University. In 2005, she joined the Faculty at Rutgers University. Dr. Quadro studies the mechanisms that regulate the maternal-fetal metabolism of essential micronutrients, such as vitamin A and its carotenoid precursor β-carotene, and their influence on mother and child health from a molecular, biochemical, and physiological perspective. She is ultimately interested in understanding how the nutritional status of a pregnant woman impacts the development and growth of her fetus, which can in turn influence the onset of chronic diseases later in childhood and adult life.
Research areas: Bone biology
Martina Rauner studied biotechnology at the University of Applied Sciences in Vienna, Austria from 2002-2006. After completing her doctorate at the Department of Pathophysiology at the Medical University of Vienna in 2008, she received the ECTS/AMGEN bone research fellowship and joined the group of Professor Lorenz Hofbauer in Dresden, Germany to study mechanisms of glucocorticoid-induced osteoporosis. In 2011, Martina became Group leader for Osteoimmunology and expanded her research area to chronic inflammatory diseases and Wnt signaling. Due to her comprehensive knowledge on bone biology, its interactions with other organ systems, and her leadership skills, she was promoted to the Scientific Director of the Bone lab in 2015 and became Professor for Molecular Bone Biology in 2018. Currently, her group is particularly interested in the interactions of bone with hematopoiesis and hormones, and studies the role of Wnt and BMP signaling.
Gabriela da Silva Xavier
Research areas: Energy homeostasis, particularly in fuel sensing mechanisms that may play a role in diabetes and obesity
Gabriela is currently Senior Lecturer in Cellular Metabolism at the University of Birmingham, having previously worked at the University of Bristol and Imperial College London. Her research interest is in mechanisms for energy homeostasis, particularly in the context of lipid metabolism, glucose tolerance, diabetes and obesity. Her group uses a variety of techniques to fully explore the mechanistic basis of metabolic dysfunction, including indirect calorimetry (CLAMS), body composition analysis (EchoMRI), analysis of bone density, structure, and function, in addition to more traditional islet biology techniques, such as islet extraction and cell culture, biochemical measurements, and real-time PCR.
Research areas: Plant biology, cell growth, cell signaling, Arabidopsis, root hairs, pollen tubes, ROS, Ca+2
Dr. José M. Estevez graduated from the School of Sciences at the University of La Plata (UNLP) in 1997 and in 2004 he obtained the PhD title under the organic chemist Dr. Alberto S. Cerezo direction from the School of Sciences at the University of Buenos Aires (UBA). From 2005 to the end of 2009 he pursued postdoctoral training in Dr. Chris Somerville's lab at the Carnegie Institution at Stanford University, USA and UC Berkeley. From 2009 to May 2015 he directed his group at IFIBYNE Institute in Argentina and in June 2015 he moved to Leloir Institute (IIBBA-CONICET) also in Argentina where he is directing the Molecular Basis of Plant Development laboratory. In addition, in 2019 he joined the Center of Plant Biotechnology (CBV) at University Andres Bello together with Millennium Institute for Integrative Biology (iBio) at Santiago, Chile. José M. Estevez is currently a Principal Researcher of National Research Council of Argentina (CONICET). José is broadly interested in how environmental signals (e.g. nutrients, salt stress, temperature), developmental programs and hormones, are all coordinated at the single plant cell level (e.g. in root hairs and pollen tubes) to define polar growth.
Research areas: Plant biology, bioinformatics, genomics
Dr. Shahid Mukhtar is an Associate Professor at the University of Alabama at Birmingham. He conducted his PhD research on Arabidopsis transcriptional regulatory networks at the Max Planck Institute Cologne, Germany. Dr. Mukhtar then carried out postdoctoral research in plant systems biology at the University of North Carolina at Chapel Hill, collaborating with the Dana Farber Cancer Institute & Center for Cancer Systems Biology, Boston. Shahid started his own laboratory at the University of Alabama at Birmingham in 2010. His research focuses at the interface of bioinformatics and life sciences. He is broadly interested in interdisciplinary research projects focused on genomics/systems biology of host plant immunity using computational approaches.
Research areas: Plant reproduction, plant protection, epigenetics
Dr. Yuan Qin is a professor of Center for Genomics and Biotechnology, Fujian Agriculture and Forestry University. Dr. Qin obtained her Ph.D. degree in developmental biology from Wuhan University in 2006. She did her postdoctoral research at the Department of Plant Science, University of Arizona and worked as an Associate Professor at Shanghai Institute of Plant Physiology and Ecology, Chinese Academy of Sciences from 2009 to 2014. She joined Fujian Agriculture and Forestry University as a Professor in 2014. Her lab research interests focus on floral stem cell determinacy, plant reproduction and plant responses to environmental stresses.
Research Gate profile
Research areas: Plant pathology, plant-microbe interactions, bioinformatics, genomics, disease diagnostics, plant immunity
Dr. Diane Saunders is a Group Leader at the John Innes Centre, UK. She obtained her PhD studying the genetic mechanisms that regulate plant pathogen development at Exeter University. She then continued to pursue her interest in the molecular mechanisms that underpin plant-pathogen interactions through her postdoctoral research at The Sainsbury Laboratory. In 2014, Diane started her own research group that focuses on (re-)emerging plant pathogens that pose a significant threat to agriculture. By studying the plant-pathogen interface her goal is to generate new knowledge that can be utilised to improve plant resistance and inform disease management strategies. Hence, her lab works on an array of topics from effector biology, fungicide resistance, genomics, plant resistance and pathogen surveillance, applying a multidisciplinary approach to the study of plant pathogen interactions. She has a particular interest in the wheat rust pathogens, which are known as the “polio of agriculture” due to the threat they pose to wheat production worldwide.
Research areas: Plant genome-editing, genetic transformation, transgenic, disease resistance
Leena Tripathi is a Plant Biotechnologist with over 21 years of experience in genetic improvement of important staple food crops for control of diseases and pests. After obtaining Ph.D., she began her career as a Research Scientist at the University of North Carolina, USA. Dr. Tripathi is currently a Principal Scientist leading the transgenic and genome editing research at the International Institute of Tropical Agriculture (IITA)-Kenya. She is also the Deputy Director of the Eastern Africa Hub and Country Representative of IITA in Kenya. She provides science leadership as a faculty member of various institutions such as Adjunct Professor at the University of Queensland, Australia, and Support Leader for CGIAR Research Program for Root, Tubers and Banana (CRP-RTB).
Her focus is on “Science to Practice” and linking scientific innovations to practical applications to solve food production. Her team has successfully established a robust genetic transformation and genome-editing platform at IITA —the only one of its kind in Africa— to develop genetically modified and genome-edited products and to transfer these technologies to national agricultural research systems in sub-Saharan Africa and beyond. The research outputs of her group have been published in over 90 articles in refereed internationally reputed journals and book chapters. Her research has been featured in more than 200 national and international news articles and documentary films. Recently, she has been honored as the fellow of the American Association for the Advancement of Science (AAAS) for her contributions to Agriculture and food security.